← Back to Search

Cord Blood Units

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

N/A
Recruiting
Research Sponsored by Center for International Blood and Marrow Transplant Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up cord blood engraftment occurs in weeks following transplant is defined as defined as anc 500/mm3 and is analyzed at 60 days post-transplant.
Awards & highlights
No Placebo-Only Group

Summary

This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.

Eligible Conditions
  • Hodgkin's Lymphoma
  • Lymphoma
  • Acute Leukemia
  • Blood Cancers
  • Metabolic disorders
  • Multiple Myeloma
  • Aplastic Anemia
  • Leukemia
  • Platelet Disorder
  • Langerhans cell histiocytosis
  • Not a Treatment Study
  • Autoimmune Diseases
  • Hemolytic Anemia
  • Autoimmune diseases

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~cord blood engraftment occurs in weeks following transplant is defined as defined as anc 500/mm3 and is analyzed at 60 days post-transplant.
This trial's timeline: 3 weeks for screening, Varies for treatment, and cord blood engraftment occurs in weeks following transplant is defined as defined as anc 500/mm3 and is analyzed at 60 days post-transplant. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Neutrophil recovery of ≥500/mm3 after cord blood transplantation

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Unlicensed CBUExperimental Treatment1 Intervention
The cohort includes recipients of any age receiving unlicensed cryopreserved cord blood units (CBUs) for designated indications.

Find a Location

Who is running the clinical trial?

National Marrow Donor ProgramOTHER
61 Previous Clinical Trials
102,627 Total Patients Enrolled
Center for International Blood and Marrow Transplant ResearchLead Sponsor
38 Previous Clinical Trials
200,093,431 Total Patients Enrolled
John Miller, MD, PhDStudy ChairNMDP/CIBMTR
~55833 spots leftby Oct 2041
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top